Related Experiment Videos

Elevated percentage of perforin positive cells in active pulmonary tuberculosis

D Nisha Rajeswari1, P Selvaraj, M S Jawahar

  • 1Tuberculosis Research Centre (ICMR), Chennai, India.

Abstract

Insights

In active pulmonary tuberculosis, CD8 cells expressing perforin increase, suggesting enhanced cell-killing activity against Mycobacterium tuberculosis. This cytotoxic response is elevated despite normal absolute counts of these cells.

Area of Science:

  • Immunology
  • Cellular Biology
  • Infectious Diseases

Background:

  • Perforin is a key molecule in cytotoxic cell function.
  • The role of perforin-positive cells in tuberculosis (TB) is not fully understood.
  • Pulmonary tuberculosis (PTB) involves complex immune responses.

Purpose of the Study:

  • To quantify circulating CD4(+) and CD8(+) perforin-positive cells in PTB patients.
  • To assess the level of cytotoxic response against Mycobacterium tuberculosis.
  • To investigate the relationship between perforin expression and TB.

Main Methods:

  • Flow cytometry was used to analyze peripheral blood lymphocytes.
  • Specific monoclonal antibodies were employed for intracellular perforin and surface CD4/CD8 staining.
  • Counts of lymphocyte subsets were compared between PTB patients and healthy individuals.

Main Results:

  • PTB patients showed significantly lower total, CD4, and CD8 lymphocyte counts compared to healthy controls.
  • An elevated percentage of total and CD8 perforin-positive cells was observed in PTB patients.
  • Absolute counts of perforin-positive cells (total, CD4, CD8) did not differ significantly between groups.

Conclusions:

  • Active pulmonary TB is associated with an increased percentage of CD8(+) perforin-positive cells.
  • These cells may exhibit heightened cytolytic activity against Mycobacterium tuberculosis.
  • Perforin expression on CD8 cells indicates an active cytotoxic response in pulmonary TB.

Related Concept Videos

Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Tuberculosis01:23

Tuberculosis

Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...